HOME >> BIOLOGY >> NEWS
New drug target and biomarker for advanced childhood cancer discovered

Scientists announced today that they have discovered a protein produced by advanced childhood cancers that provides a new target for treatments and a new marker for the disease. Separately, researchers reported data on the crystal structures of two kinase proteins implicated in multiple cancers. The data on structure provides valuable information for the design of cancer therapeutics targeted at these proteins. The studies were presented today at the International Conference on Molecular Targets and Cancer Therapeutics organized by the American Association of Cancer Research (AACR), National Cancer Institute (NCI) and European Organisation for Research and Treatment of Cancer (EORTC) in Boston.

Identification of a novel secretory protein specific to neuroblastoma: Abstract 1216

A new protein found only in the cells of neuroblastoma, a common childhood cancer, could provide clues to differentiating between aggressive tumors and those that are more likely to respond to treatment, said Baylor College of Medicine researchers who discovered it.

The gene that codes for the protein, called neuroblastoma-derived secreted protein or NDSP, is most active in severe cases of neuroblastoma, said Dr. Jianhua Yang, assistant professor of pediatrics/hematology and oncology, at Baylor College of Medicine in Houston. As such, the protein could provide important information about the recurrence of disease after first treatment, said Dr. Jed Nuchtern, associate professor of pediatrics/surgery at Baylor College of Medicine.

"We know there are some tumor cells left after surgery and chemotherapy because of the high relapse rate," Dr. Nuchtern said. "This gene may make possible a sensitive means of detecting those."

Dr. Yang discovered the gene, a novel structure, during a screening using microarray technology. He subsequently discovered the gene was only expressed in neuroblastoma cells. So far, Dr. Yang has only tested neuroblastoma cell lines
'"/>

Contact: Warren Froelich
froelich@aacr.org
215-440-9300
American Association for Cancer Research
19-Nov-2003


Page: 1 2 3

Related biology news :

1. International study findings link acne-like rash to effectiveness of new targeted cancer treatment
2. Safety of isoflavones in dietary supplements targeted by Illinois initiative
3. Cancer vaccine based on pathogenic listeria bacteria shows promise targeting metastases
4. Evidence builds for potential new cancer drug target
5. UCI scientists successfully target key HIV protein; breakthrough may lead to new drug therapies
6. Images of tail of protein needed for cell multiplication suggest anticancer drug targets
7. Diabodies act as guided missiles targeted to mammary tumor growth
8. Anticancer drug zebularine specifically targets tumor cells
9. Study suggests cell-cycle triggers might be cancer drug targets
10. Sweet success in targeting sugar molecules to cells in living animals
11. Retroviral gene therapy? ASLV, HIV, and MLV show distinct target site preferences

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... October 15, 2019 , ... The scope of the ... Microbiology International currently manufactures ready-to-use culture broth and buffers in its proprietary MediaBox™ ... liquid supplements. , This major step underpins the company’s philosophy of offering the ...
(Date:10/17/2019)... ... 2019 , ... The International Society for Pharmaceutical Engineering ... Water and Steam Systems (Third Edition) . This guide provides in-depth guidance for ... professionals can better understand Good Manufacturing Practices (GMPs), to comply with established regulations ...
(Date:10/17/2019)... ... October 16, 2019 , ... Advanced Clinical, a clinical ... continues with the opening of new offices in Bucharest and Timisoara, Romania. Advanced ... country’s accelerated growth in clinical trials. , Advanced Clinical’s entrance into Romania ...
Breaking Biology News(10 mins):
(Date:10/15/2019)... ... October 14, 2019 , ... ARPR , an award-winning tech PR agency at ... as a Health Care Agency of the Year in the Ragan’s Health Care PR ... a finalist by Ragan’s. The firm also revealed today that its healthIT practice group grew ...
(Date:10/10/2019)... ... October 10, 2019 , ... R3 Stem Cell announces it ... is October 18-19th, 2019 in Las Vegas with spots still open. , The speaker, ... at several Ivy League universities including Cornell, Harvard and Dartmouth. He currently serves as ...
(Date:10/8/2019)... ... October 07, 2019 , ... Erchonia Corporation, ... technology (“3LT®”), today announces that the U.S. Food and Drug Administration (FDA) has ... for the temporary relief of chronic neck and shoulder pain of musculoskeletal origin. ...
(Date:10/3/2019)... ... ... Cheyenne is a beautiful and strong Quarter Horse and a huge part of ... , which offers riding lessons and trail riding in Afton, Virginia. According to ... her as her “go to horse.” Thus, you can imagine the devastation when ...
Breaking Biology Technology:
Cached News: